These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1247 related items for PubMed ID: 15525341

  • 21. Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens.
    Legault M, Wise RA.
    Synapse; 1999 Mar 15; 31(4):241-9. PubMed ID: 10051104
    [Abstract] [Full Text] [Related]

  • 22. Stimulation of N-methyl-D-aspartate receptors, AMPA receptors or metabotropic glutamate receptors leads to rapid internalization of AMPA receptors in cultured nucleus accumbens neurons.
    Mangiavacchi S, Wolf ME.
    Eur J Neurosci; 2004 Aug 15; 20(3):649-57. PubMed ID: 15255976
    [Abstract] [Full Text] [Related]

  • 23. Low-level N-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-methyl-D-aspartate-mediated neurotransmission in the cortex.
    Craig CG, White TD.
    J Pharmacol Exp Ther; 1992 Mar 15; 260(3):1278-84. PubMed ID: 1312166
    [Abstract] [Full Text] [Related]

  • 24. Chronic morphine treatment selectively augments metabotropic glutamate receptor-induced inhibition of N-methyl-D-aspartate receptor-mediated neurotransmission in nucleus accumbens.
    Martin G, Przewlocki R, Siggins GR.
    J Pharmacol Exp Ther; 1999 Jan 15; 288(1):30-5. PubMed ID: 9862749
    [Abstract] [Full Text] [Related]

  • 25. Involvement of NMDA receptor mechanisms in the modulation of serotonin release in the lateral parabrachial nucleus in the rat.
    Tanaka J, Miyakubo H, Kawakami A, Hayashi Y, Nomura M.
    Brain Res Bull; 2006 Dec 11; 71(1-3):311-5. PubMed ID: 17113961
    [Abstract] [Full Text] [Related]

  • 26. Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release.
    Zmarowski A, Sarter M, Bruno JP.
    Synapse; 2007 Mar 11; 61(3):115-23. PubMed ID: 17146770
    [Abstract] [Full Text] [Related]

  • 27. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C, Weiss M, Rostain JC.
    Brain Res; 2007 Oct 24; 1176():37-44. PubMed ID: 17900538
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR, Liljequist S.
    J Pharmacol Exp Ther; 2004 Nov 24; 311(2):560-7. PubMed ID: 15256539
    [Abstract] [Full Text] [Related]

  • 30. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.
    Brain Res; 2008 Mar 10; 1198():44-54. PubMed ID: 18261716
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
    Trevitt J, Kawa K, Jalali A, Larsen C.
    Pharmacol Biochem Behav; 2009 Nov 10; 94(1):24-9. PubMed ID: 19602422
    [Abstract] [Full Text] [Related]

  • 34. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
    Mihara T, Mihara K, Yarimizu J, Mitani Y, Matsuda R, Yamamoto H, Aoki S, Akahane A, Iwashita A, Matsuoka N.
    J Pharmacol Exp Ther; 2007 Nov 10; 323(2):708-19. PubMed ID: 17684118
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.
    Peleg-Raibstein D, Pezze MA, Ferger B, Zhang WN, Murphy CA, Feldon J, Bast T.
    Neuroscience; 2005 Nov 10; 132(1):219-32. PubMed ID: 15780480
    [Abstract] [Full Text] [Related]

  • 38. Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.
    Gomes CA, Vaz SH, Ribeiro JA, Sebastião AM.
    Brain Res; 2006 Oct 03; 1113(1):129-36. PubMed ID: 16935271
    [Abstract] [Full Text] [Related]

  • 39. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
    Pickel VM, Colago EE, Mania I, Molosh AI, Rainnie DG.
    Neuroscience; 2006 Oct 27; 142(3):671-90. PubMed ID: 16905271
    [Abstract] [Full Text] [Related]

  • 40. NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release.
    Zmarowski A, Sarter M, Bruno JP.
    Eur J Neurosci; 2005 Oct 27; 22(7):1731-40. PubMed ID: 16197513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 63.